genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Broccoli Ingredient Suppresses Tumor Growth in Cancer Mouse Model
Neuroscience
Huntington’s Disease Gets New Onset Age Predictor
Genetics
Our Genes Have a Major Influence on Whether We Choose to…
News
Over 99% of CTCs Captured on New Microfluidic Chip
News
Genentech, Parvus Therapeutics Launch Up-to-$800M Autoimmune Collaboration
Insights
Tech Exclusives
Rising to the Challenge of Intensifying Bioprocesses
May 2019 Vol. 39 No. 5
A Scalable Adenovirus Production Process from Cell Culture to Purified Bulk…
May 2019 Vol. 39 No. 5
Genomics’ “Green” Future
Tech Exclusives
Microbial Culture Systems for Bioprocessing
Insights
Phage Therapy Win: Mycobacterium Infection Halted
A-Lists
A-Lists
Top 10 Under 40 of 2019
Insights
Top 10 Best-Selling Cancer Drugs of 2018
Insights
Top 10 Sequencing Companies
May 2019 Vol. 39 No. 5
Top 10 Immuno-Oncology Collaborations
A-Lists
Top 15 Best-Selling Drugs of 2018
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Broccoli Ingredient Suppresses Tumor Growth in Cancer Mouse Model
Genetics
Our Genes Have a Major Influence on Whether We Choose to…
News
Over 99% of CTCs Captured on New Microfluidic Chip
News
Genentech, Parvus Therapeutics Launch Up-to-$800M Autoimmune Collaboration
Magazine
May 2019 Vol. 39 No. 5
A Scalable Adenovirus Production Process from Cell Culture to Purified Bulk…
May 2019 Vol. 39 No. 5
Genomics’ “Green” Future
May 2019 Vol. 39 No. 5
Crafting a More Efficient CAR T-Cell Industry
May 2019 Vol. 39 No. 5
All About That Base Editing
May 2019 Vol. 39 No. 5
Signs, Portents, and Immuno-Oncology Biomarkers
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Podcasts
GENcast: Explore, Learn, and Collaborate on Viral Safety in Biomanufacturing
May 2019 Vol. 39 No. 5
A Scalable Adenovirus Production Process from Cell Culture to Purified Bulk…
Upcoming Webinars
Recent Advances and the Future of Antibody Engineering
Videos
3D Bioprinted Organ Just Took Its First “Breath”
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Companies
AstraZeneca
AstraZeneca
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
AstraZeneca
AveXis to Acquire AstraZeneca Manufacturing Site in Longmont, CO
AstraZeneca
AstraZeneca, Daiichi Sankyo Launch Potentially $6.9B+ Collaboration to Develop Cancer ADC
AstraZeneca
Moderna Raises Size of its Largest-Ever Biotech IPO to $600M
AstraZeneca
AstraZeneca’s Imfinzi Fails 2nd Primary Endpoint in Phase III MYSTIC Trial
AstraZeneca
Sobi Buys Synagis U.S. Rights, Half Share of MEDI18897 U.S. Profits from AstraZeneca
AstraZeneca
Grünenthal Acquires Partial Rights to Nexium, Vimovo from AstraZeneca for Up-to-$922M
AstraZeneca
After Second Phase III Failure, AstraZeneca Retreats from COPD Filing Plans...
AstraZeneca
AstraZeneca Weighs Expanding Fasenra to COPD after Phase III Failure
AstraZeneca
AstraZeneca, SWIBCo Launch Stem Cell Cardiovascular Therapy Collaboration
AstraZeneca
After Patient Dies, FDA Imposes Clinical Hold on Trial of Advaxis/AstraZeneca...
AstraZeneca
With $250M in Financing, AstraZeneca Spinout to Focus on Severe Autoimmune...
AstraZeneca
Bavarian Nordic Launches Study of Cancer Vaccine CV301 with AstraZeneca’s Imfinzi
AstraZeneca
Moderna Raises $500M Financing for mRNA R&D, Manufacturing
AstraZeneca
Regeneron to Lead $50M Exome Sequencing Consortium with UK Biobank
AstraZeneca
PhaseBio Inks License to Develop MedImmune’s Reversal Agent for Blood Thinner
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
